Centessa Pharmaceuticals

Company snapshot

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with a Research & Development innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We are led by a management team with extensive R&D

• 15 active pipeline program(s) linked via ClinicalTrials.gov.
• 7 US patent(s) indexed to this assignee profile.
• 15 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Centessa Pharmaceuticals. Not investment advice.

• approval Jun 1, 2026

  Eli Lilly Acquires Centessa Pharmaceuticals: Market Analysis

• Peer + 0 momentum

  Eikon Therapeutics

  TA overlap score 23

Recent activity

Latest pipeline, patent, and corporate events for Centessa Pharmaceuticals.

1. Jun 8, 2026 Clinical update

   LB101-101 — Phase 2

2. Jun 8, 2026 Clinical update

   ORX750-202 — Phase 2

3. Jun 8, 2026 Clinical update

   ORX750-0201 — Phase 2

4. Jun 5, 2026 Clinical update

   ZF874 — Phase 1

5. Jun 5, 2026 Clinical update

   SerpinPC — Phase 2

View all clinical trial activity →

• What is Centessa Pharmaceuticals?

  Centessa Pharmaceuticals is a pharma organization headquartered in Cheshire, GB. It trades on NYSE under ticker CNTA. Primary therapeutic focus areas include Narcolepsy and Idiopathic Hypersomnia, Narcolepsy Type 1, Advanced solid tumors, Chronic Inflammatory Disease, Cutaneous S

• Is Centessa Pharmaceuticals publicly traded?

  Yes. Centessa Pharmaceuticals is listed with ticker CNTA on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Centessa Pharmaceuticals develop or market?

  We link 11 drug profile(s) where Centessa Pharmaceuticals is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/centessa-pharmaceuticals-plc#company-drugs.

• What are the latest developments for Centessa Pharmaceuticals?

  In the last 12 months our linked public records show 15 trial program update(s) and 3 US patent grant(s) tied to this profile.

• What therapeutic areas does Centessa Pharmaceuticals focus on?

  Centessa Pharmaceuticals focuses on Narcolepsy and Idiopathic Hypersomnia, Narcolepsy Type 1, Advanced solid tumors based on our analysis of their pipeline programs and drug development activities.